Bruker Corporation
40 Manning Road
Manning Park
Billerica
Massachusetts
01821
United States
568 articles about Bruker Corporation
-
Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
3/11/2024
At the 20th US Human Proteome Organization Congress 2024, Bruker Corporation announced progress in immunopeptidomics, glycoproteomics and other CCS-enabled 4D-proteomics workflows.
-
Bruker Announces Closing of Chemspeed Technologies AG Acquisition
3/7/2024
Bruker Corporation (Nasdaq: BRKR) is pleased to announce the successful closing of its acquisition of Chemspeed Technologies AG, a leading Swiss provider of automated laboratory R&D and QC workflow solutions.
-
Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup
2/28/2024
Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup.
-
Bruker Corporation to Present at Upcoming Investor Conferences - February 26, 2024
2/26/2024
Bruker Corporation announced that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at the following investor conferences.
-
Bruker Announces Quarterly Dividend - February 16, 2024
2/16/2024
Bruker Corporation announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock.
-
Bruker Reports Fourth Quarter and Full Year 2023 Financial Results
2/13/2024
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2023.
-
Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience
2/7/2024
Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Nanophoton Corporation, a pioneer focused on advanced research Raman microscopy systems.
-
Bruker Announces Date and Time of Fourth Quarter 2023 Earnings Release and Webcast
2/6/2024
Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2023 financial results before market opening on Tuesday, February 13, 2024.
-
Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems
2/6/2024
Bruker Corporation announced that it has acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo optical imaging systems.
-
Bruker Introduces the Ingenious Novel ‘Triceratops’ SPR #64 Surface Plasmon Resonance System for Drug Discovery at SLAS2024
2/5/2024
Bruker Introduces the Ingenious Novel ‘ Triceratops ’ SPR #64 Surface Plasmon Resonance System for Drug Discovery at SLAS2024.
-
Bruker Announces Agreement to Acquire Chemspeed
1/25/2024
Bruker Corporation (Nasdaq: BRKR) today announced a definitive agreement for the acquisition of Chemspeed Technologies AG , a Swiss provider of vendor-agnostic automated laboratory R&D and QC workflow solutions.
-
Bruker Announces Acquisition of Tornado Spectral Systems to Expand Its Biopharma Process Analytical Technology (PAT) Product Portfolio
1/4/2024
Bruker (Nasdaq: BRKR) today announced the acquisition of Tornado Spectral Systems Inc.
-
Bruker Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
1/3/2024
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 42nd annual J.P. Morgan Healthcare Conference in San Francisco.
-
Bruker Acquires Electron Microscopy Company Nion
1/3/2024
Bruker announced that it has acquired Nion, a privately-held company that develops and manufactures innovative high-end scanning transmission electron microscopes.
-
Bruker Announces First 1.2 GHz NMR Installation in the United States at The Ohio State University - Funded by the U.S. National Science Foundation
12/19/2023
Bruker Corporation announced the successful installation of a 1.2 Gigahertz NMR system at the National Gateway Ultrahigh Field NMR Center at The Ohio State University.
-
Bruker Announces Quarterly Dividend - November 20, 2023
11/20/2023
Bruker Corporation announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock.
-
Bruker Corporation to Participate in the 2023 Jefferies London Healthcare Conference
11/7/2023
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2023 Jefferies London Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer will present and participate in an analyst moderated question and answer session on behalf of the Company on Tuesday, November 14, 2022 at 8:30 AM GMT (3:30 AM Eastern Time).
-
Bruker Reports Third Quarter 2023 Financial Results
11/2/2023
Bruker Corporation announced financial results for its third quarter and for the nine months ended September 30, 2023.
-
Bruker Announces Date and Time of Third Quarter 2023 Earnings Release and Webcast
10/27/2023
Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2023 financial results before market opening on Thursday, November 2, 2023.
-
Valo Therapeutics Announces Acquisition of Bruker Corporation’s Latest Mass Spectrometer Platform for Tumor Antigen Identification with ValoTx’s PeptiCHIP Technology
10/10/2023
Valo Therapeutics Oy announces it is the first biotech company in Europe to install and use the Bruker Corporation’s new timsTOF Ultra mass spectrometer and liquid chromatography platform, which provides transformative speed and sensitivity for antigen identification in connection with ValoTx’s PeptiCHIP technology.